Get in touch

Industrial Localization & Tech Transfer

Strategic advisory for international firms looking to localize manufacturing, clinical operations, and technology transfer in Saudi Arabia in alignment with Vision 2030.

Built for Manufacturers Entering Saudi Arabia

We help international MedTech companies translate localization goals into practical regulatory, operational, and transfer plans for the Saudi market.

International Manufacturers

Plan local manufacturing pathways while protecting product quality, regulatory continuity, and global standards.

Technology Owners

Structure transfer packages that make processes, validation evidence, and know-how ready for local execution.

Saudi Industrial Partners

Align facility readiness, quality systems, and regulatory expectations before onboarding new technologies.

Clinical & R&D Teams

Prepare regional clinical, usability, and validation activities that support local market entry.

Localization Strategy Without Regulatory Drift

Our work connects commercial ambition, Vision 2030 priorities, and regulated manufacturing requirements into a clear execution plan.

Localization Feasibility Mapping

We assess product category, manufacturing complexity, supply chain needs, and Saudi regulatory implications before localization begins.

Technology Transfer Planning

We define transfer scope, process knowledge, validation evidence, training needs, and documentation required for local execution.

Facility & QMS Readiness

We review local partner readiness against ISO 13485 expectations, process controls, and medical device regulatory requirements.

Regulatory Pathway Alignment

We align localization plans with SFDA expectations, market authorization strategy, and lifecycle change control obligations.

Clinical & Operational Localization

We support regional clinical trial, usability, and post-market planning where local evidence or operational adaptation is needed.

How We Work

A structured approach to turn localization intent into a compliant, executable transfer roadmap.

Assess

Review product, process, market goals, and localization feasibility.

Map

Define transfer scope, regulatory impact, and partner readiness needs.

Prepare

Build documentation, validation, training, and QMS alignment plans.

Transfer

Support controlled handover of process knowledge and operational requirements.

Sustain

Maintain compliance through change control, PMS, and continuous improvement.

Key Deliverables

Clear outputs that drive compliance, reduce risk, and accelerate your time to market.

01

Localization Feasibility Report

A focused assessment of Saudi localization suitability, risks, and priority actions.

02

Technology Transfer Roadmap

A staged plan covering process transfer, documentation, validation, and training.

03

Partner Readiness Assessment

Review of facility, QMS, and operational gaps before local implementation.

04

Regulatory Impact Memo

Analysis of how localization affects SFDA submissions, approvals, and lifecycle controls.

05

Implementation Action Plan

Prioritized steps for moving from strategy to controlled local execution.

Build a Complete Regulatory Ecosystem .

LexoraMed provides integrated regulatory support across Saudi Arabia, GCC, and global markets — helping manufacturers move from strategy to authorization with confidence and clarity.

Medical Device Market Authorization

Advisory on securing MDMA, SFDA approvals, and global authorization pathways for regional and international market entry.

Read More

Technical File Assessment

Leading comprehensive reviews of innovative device dossiers, successfully translating advanced clinical data, cybersecurity parameters, and biocompatibility profiles into robust regulatory submissions.

Read More

Post-Market Surveillance

Ongoing compliance, vigilance, safety monitoring, reporting, and lifecycle support after market authorization.

Read More

Frequently Asked Questions

Clear answers to the most common regulatory and compliance questions manufacturers ask before entering Saudi Arabia and global markets.

Can localization begin before full Saudi market authorization? +
Yes, but the transfer plan should be aligned early with the intended SFDA pathway so manufacturing, documentation, and validation evidence remain usable for authorization.
Do you support international manufacturers without a Saudi partner yet? +
Yes. We can define localization requirements first, then help evaluate what a qualified local partner or facility should be able to support.
Is technology transfer only for manufacturing? +
No. It can include manufacturing processes, clinical operations, quality controls, documentation systems, training, and post-market responsibilities.
How does Vision 2030 affect the localization strategy? +
Vision 2030 creates strong strategic incentives for local capability building, but the plan must still satisfy medical device quality, safety, and regulatory requirements.